Imumune Thrombocytopenia(ITP) Human Mass Balance

Hematology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

H
HutchmedChina - Hong Kong
1 program
1
HMPL-523Phase 11 trial
Active Trials
NCT05781906Completed6Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
HutchmedHMPL-523

Clinical Trials (1)

Total enrollment: 6 patients across 1 trials

NCT05781906HutchmedHMPL-523

Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects

Start: Feb 2023Est. completion: Dec 20236 patients
Phase 1Completed

Related Jobs in Hematology

Senior Manager – Strategy & Business Transformation

Johnson & Johnson
Mumbai, India
2d ago

MSL Hematología L - Sur

Johnson & Johnson
Sevilla, Spain
2d ago

Délégué Médical LLC/Myélome (H/F) - secteurToulouse

Johnson & Johnson
Issy-les-Moulineaux, France
2d ago

Sr. Director Marketing

Genetix Biotherapeutics
Somerville, Massachusetts, United States
4d ago
From $270K/yr

Commercial Strategy Lead – Innovative Gene Therapies (Haematology - BeNeLux)

Vertex Pharmaceuticals
5065 - Vertex Netherlands
5d ago

Key Account Specialist Hematology

Johnson & Johnson
Beirut, Lebanon
5d ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Anemia(92)Myelofibrosis(21)Polycythemia Vera(16)Primary Immune Thrombocytopenia(15)Primary Myelofibrosis(14)Immune Thrombocytopenia(12)Thrombocytopenia(11)Beta-Thalassemia(10)Aplastic Anemia(7)Anemia of Chronic Kidney Disease(7)